700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ ReadersThis Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
|Alban Phamra(Hong Kong) Co., Ltd, China|
|ScientificTracks Abstracts: J Bioanal Biomed|
|GMP represents a quality management system manufacturing and submission of biological products. For filing IND in biological products for clinical studies, GMP compliance is required at the different levels. The topic shall address GMP conditions and GMP compliances from Phase-I, Phase-2, Phase-3 clinical studies through commercialization with MA.|
Frank Cheng is the Founder and Principle Senior Consultant of Alban Pharma, Hong Kong, which is a leading consulting company on biosimilar development and submission to EU and US. With his PhD from Canada and PDF experiences from JHU in USA, he is now directing and managing several biosimilar projects from GMP compliance to design and implementation of regulatory submission roadmaps.
Email: [email protected]
|PDF | HTML|